Skip to content
Governance Register

← US public companies

Calithera Biosciences, Inc.

SEC CIK 1496671 · CALA · last insider filing 2023-05-26

Directors (from insider filings)

NameCapacity as filedFilings
Pakianathan Deepika Director filed 2014 - 2023
Molineaux Susan Director · PRESIDENT AND CEO filed 2014 - 2023
Wolff Henry Ward Director filed 2014 - 2022
Garland J. Scott Director filed 2020 - 2022
Agarwal Sunil Director filed 2015 - 2022
Wise Blake Director filed 2017 - 2022
Orford Keith Director · SR. VP, CLINICAL DEVELOPMENT filed 2016 - 2022
Jones Suzy Director filed 2016 - 2022
Drachman Jonathan G Director filed 2014 - 2021
George Jean Director filed 2014 - 2021
Christoffersen Ralph E Director filed 2014 - 2014

Officers (from insider filings)

NameTitle as filedFilings
Wong Stephanie VP, FINANCE AND SECRETARY filed 2017 - 2023
Sjogren Eric SR. VP, DRUG DISCOVERY filed 2014 - 2023
Molineaux Christopher SR. VP, DRUG DEVELOPMENT filed 2014 - 2023
Kuriakose Emil CHIEF MEDICAL OFFICER filed 2021 - 2023
Ray Sumita See Remarks filed 2017 - 2022
Parlati Francesco VP, RESEARCH filed 2017 - 2022
Hecht Curtis VP, BUS. & CORP. DEVELOPMENT filed 2014 - 2021
Waddill William D. SR. VP & CFO filed 2014 - 2016
Bennett Mark K SR. VP, RESEARCH filed 2014 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.